Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Misdiagnosis of Human Herpes Virus-8-Associated Kaposi's Sarcoma as Adverse Drug Eruptions

  • Kim, Tae Hyung (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine) ;
  • Wee, Syeo Young (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine) ;
  • Jeong, Hyun Gyo (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine) ;
  • Choi, Hwan Jun (Department of Plastic and Reconstructive Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine)
  • Published : 2022.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Kaposi's sarcoma (KS) is a cancer that causes patches of abnormal tissue to grow under the skin. It also occurs in the immunosuppressive population. KS is currently believed to be caused by infection with human herpes virus-8 (HHV-8) in non-human immunodeficiency virus patient. A 79-year-old female visited the outpatient clinic presenting with increasing number and size of palpable masses on both upper and lower extremities. She was first diagnosed as drug-erupted dermatitis and stopped her medications, but the symptoms got worse. We did partial biopsy, and KS with HHV-8 was diagnosed histopathologically. She planned to undergo further evaluations and proper treatments. This rare case suggests the need to consider a classic type of KS in the differential diagnosis of specific dermatologic symptoms such as macular, nodular, and darkish patches of upper or lower extremities in elderly patients. It is believed that this case helps to strengthen awareness of this rare disease.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MSIT; 2020R1A2C1100891), and was supported by Soonchunhyang University research fund.

References

  1. Nickoloff BJ, Foreman KE. Etiology and pathogenesis of Kaposi's sarcoma. In: Dummer R, Nestle FO, Burg G., eds. Cancers of the Skin. vol. 160, Berlin, Heidelberg:: Springer;; 2002:331-342
  2. Kamiyango W, Villiera J, Silverstein A, Peckham-Gregory E, Campbell LR, El-Mallawany NK. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev 2019;38(04):749-758 https://doi.org/10.1007/s10555-019-09823-3
  3. Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28(03):371-395 https://doi.org/10.1016/0190-9622(93)70057-Z
  4. Schwartz RA. Kaposi's sarcoma: an update. J Surg Oncol 2004;87(03):146-151 https://doi.org/10.1002/jso.20090
  5. Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol 2008;53(01):2-8 https://doi.org/10.4103/0019-5154.39732
  6. Vangipuram R, Tyring SK. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int J Dermatol 2019;58(05):538-542 https://doi.org/10.1111/ijd.14080
  7. Rescigno P, Di Trolio R, Buonerba C, et al. Non-AIDS-related Kaposi's sarcoma: a single-institution experience. World J Clin Oncol 2013;4(02):52-57 https://doi.org/10.5306/wjco.v4.i2.52
  8. Lanternier F, Lebbe C, Schartz N, et al. Kaposi's sarcoma in HIV-negative men having sex with men. AIDS 2008;22(10):1163-1168 https://doi.org/10.1097/QAD.0b013e3283031a8a
  9. Krown SE, Lee JY, Lin L, et al. Interferon-a2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma. J Acquir Immune Defic Syndr 2006;41:5
  10. Oyucu Orhan S, Bilgehan Sahin A, Cubukcu E, et al. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: a single-center retrospective real-world data. Bosn J Basic Med Sci 2021;21(06):746-751
  11. Reid E, Suneja G, Ambinder RF, et al; CGC. AIDS-related Kaposi sarcoma, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(02):171-189 https://doi.org/10.6004/jnccn.2019.0008
  12. Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol 2017;18(04):529-539 https://doi.org/10.1007/s40257-017-0270-4
  13. Krown SE, Moser CB, MacPhail P, et al;A5263/AMC066 protocol team. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet 2020;395(10231):1195-1207 https://doi.org/10.1016/s0140-6736(19)33222-2
  14. Tsao MN, Sinclair E, Assaad D, et al. Radiation therapy for the treatment of skin Kaposi sarcoma. Ann Palliat Med 2016;5(04):298-302 https://doi.org/10.21037/apm.2016.08.03
  15. Lebbe C, Garbe C, Stratigos AJ, et al;European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC) Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer 2019;114:117-127 https://doi.org/10.1016/j.ejca.2018.12.036